Samedan Ltd Pharmaceutical Publishers

Archive of previous issues

Subscribe ONLINE

Pharmaceutical Industry Comprehensive Directory

Industry Events Calendar

News and Press Releases

Employment Opportunities

Advertising with us

Air Transport Publications

home > ebr

PUBLICATIONS

European BioPharmaceutical Review

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.

With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:
Advertising Neil Clarke	Editorial Themis Bakas

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

BioDiscovery Technology
Matthew Segall at the ADMET Division, BioFocus DPI puts forward the question affecting almost every biopharmaceutical company: Why is it Still Drug Discovery? He investigates why the research and development process for the pharmaceutical industry is both expensive and of long duration, resulting in many failed projects

BioBusiness Development
Collaborate to Innovate is the message Heather Fraser at the IBM Institute for Business Value aims to convey. Biopartnering, if executed efficiently, can reap generous rewards both in terms of business success and product innovation, transforming the way in which businesses conduct such deals

BioDevelopment and Regulatory
When Oral Bioavailability Becomes a Problem, it is crucial that companies assess the need for reliable prediction of preclinical bioavailability as well as the other limiting factors affecting this issue, assert Florence Salmon, Miriam Verwei and Robert Havenaar of TNO

Edited by
Dr Helen Tayton-Martin,
Corporate & Business
Development Specialist,
Life Science

Published quarterly in
February, May,
August and November

EBR e-Book

Industry Events

EuroBiopartnering 2008

7-9 October 2008, Paris, France

EuroBiOpartnering 2008 gives you the unique opportunity to meet the relevant decision makers and opinion leaders from the international biotech community and offers you 3 days of partnering opportunities including one-to-one meetings, company presentations and further networking activities… Learn more
More info >>

All events >>

News and Press Releases

New PFA SonicLine® ultrasonic flowmeters

Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLine® ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLine® is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >>

All releases >>